Weekend
Home Calendar Movers Compare
S&P 500 741.77 +0.54% Nasdaq 721.34 +0.59% Dow 30 513.08 +0.73% Apple 291.13 -1.52% Nvidia 177.39 +0.93% Tesla 406.43 +1.82%
Weekend | 43 companies reporting this week
Home / Calendar / NAMS

NAMS

NewAmsterdam Pharma Company NV
$30.40
90-day price trend
+0.46% (+$0.14)
Volume 673,540
52W High $42.21
52W Low $17.63
Market Cap $3.56B
← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported
May 14, 2026 Beat
Actual: -$0.34 vs. Consensus: -$0.47

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q1 2026 May 14, 2026
1-Day: -3.90%
5-Day: -8.57%
Q1 2026 May 7, 2026
1-Day: +11.13%
5-Day: +11.59%
Q4 2025 Mar 4, 2026
1-Day: -3.34%
5-Day: -1.31%
Q4 2025 Feb 25, 2026
1-Day: -2.09%
5-Day: -6.23%

Revenue & Financial Performance

Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $32,000 -99.8% -84.4% -10,000.0% -$74.9M
Q3'25 $348,000 -98.8% 100.0% -10,000.0% -$72.0M
Q2'25 $19.1M +740.1% 100.0% -186.1% -$17.4M
Q1'25 $3.0M +112.6% 100.0% -2,314.5% -$39.5M
Q4'24 $12.8M +1,490.5% 100.0% -338.5% -$92.2M
Q3'24 $29.1M +889.8% 100.0% -85.9% -$16.6M
Q2'24 $2.3M +32.7% 100.0% -2,306.9% -$39.0M
Q1'24 $1.4M -83.8% 100.0% -3,960.2% -$93.8M

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q1 2026 May 14, 2026 -$0.47 -$0.46 -$0.34 +27.93% Beat
Q1 2026 May 7, 2026 -$0.47 -$0.42 -$0.34 +27.93% Beat
Q4 2025 Mar 4, 2026 -$0.40 -$0.40 -$0.53 -32.74% Missed
Q4 2025 Feb 25, 2026 -$0.37 -$0.37 -- -- --
Q4 2025 Feb 18, 2026 -$0.40 -$0.40 -$0.53 -32.74% Missed
Q3 2025 Nov 5, 2025 -$0.40 -$0.41 -$0.61 -51.25% Missed
Q2 2025 Aug 7, 2025 -$0.44 -$0.44 -$0.15 +65.91% Beat
Q2 2025 Aug 6, 2025 -$0.44 -$0.44 -$0.15 +65.91% Beat
Q1 2025 May 8, 2025 -$0.44 -$0.44 -$0.30 +31.82% Beat
Q4 2024 Feb 26, 2025 -$0.96 -$0.96 -$0.93 +3.12% Beat
Q3 2024 Nov 6, 2024 -$0.45 -$0.45 -$0.16 +64.44% Beat
Q2 2024 Aug 7, 2024 -$0.52 -$0.52 -$0.38 +26.92% Beat

Company Information

Symbol
NAMS
Company
NewAmsterdam Pharma Company NV
Market Cap
$3.56B
include __DIR__ . '/includes/footer.php'; ?>